Nanite
Sean Kevlahan is an accomplished executive with extensive experience in the biotechnology sector. As the Chief Executive Officer and Co-Founder of Nanite, as well as Quad Technologies, Sean has demonstrated leadership in driving innovative solutions within the industry. Previously, Sean served as Senior Director of Cell and Gene Therapy at Bio-Techne, contributing significant expertise in advancing therapeutic technologies. Academic credentials include a PhD in Chemical Engineering from Northeastern University and a B.S. in Biochemistry from Hofstra University.
This person is not in any offices
Nanite
Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.